<DOC>
	<DOC>NCT00370786</DOC>
	<brief_summary>To evaluate the effect of bevacizumab for treatment of non-AMD choroidal neovascularization (CNV); eg:angioid streaks, ocular histoplasmosis, high myopia, idiopathic,etc</brief_summary>
	<brief_title>Effect of Intravitreal Bevacizumab on Non -Age-Related Macular Degeneration (AMD) Related Choroidal Neovascularization (CNV)</brief_title>
	<detailed_description />
	<mesh_term>Choroidal Neovascularization</mesh_term>
	<mesh_term>Neovascularization, Pathologic</mesh_term>
	<mesh_term>Bevacizumab</mesh_term>
	<criteria>Cases with subfoveal or juxtafoveal CNV due to a nonAMD related cause. Evidence of AMD</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>Choroidal neovascularization (CNV)</keyword>
	<keyword>Bevacizumab</keyword>
	<keyword>Non AMD</keyword>
	<keyword>High myopia</keyword>
	<keyword>angioid streaks</keyword>
	<keyword>Ocular histoplasmosis</keyword>
	<keyword>Idiopathic</keyword>
</DOC>